Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07507344Not ApplicableRecruiting

Beverage Hydration Index of Different Solutions

Role: collaborator

NCT05185024Not ApplicableCompleted

Daily Oral Iron Supplementation for Replenishment of Depleted Iron in Adults

Role: lead

NCT05945667Not ApplicableCompleted

Efficacy and Safety of Uronext® in Women With Cystitis

Role: lead

NCT04713943Not ApplicableCompleted

Efficacy of >Your< Iron Syrup Supplementation in Children With Dietary Iron Deficiency

Role: lead

All 4 trials loaded